Il aura fallu plus de 20 ans avant que nos concepts scientifiques soient traduits en traitement pour le diabte, et prs de 10 ans de plus avant que lon commence parler de la perte de poids, raconte lendocrinologue canadien Daniel Drucker
Understanding Mounjaro for Managing Type 2 Diabetes Mounjaro, a branded medication from Eli Lilly, features the active ingredient tirzepatide and is specifically approved by the FDA for treating type 2 diabetes in adults
usually improves over several weeks Diarrhoea or constipation : Altered bowel habits due to delayed gastric emptying Abdominal discomfort : Bloating, dyspepsia, or gastro-oesophageal reflux symptoms Practical management strategies recommended by NICE and specialist diabetes services include: Starting at the lowest licensed dose and titrating gradually according to the product's summary of product characteristics Eating smaller, more frequent meals and avoiding high-fat foods Maintaining adequate hydration, particularly if experiencing vomiting or diarrhoea Taking the injection at a consistent time as specified in the SmPC for your particular medication Less common but important adverse effects include: Injection site reactions : Rotate injection sites systematically between abdomen, thigh, and upper arm to minimise localised reactions Hypoglycaemia : Risk increases when GLP-1 agents are combined with insulin or sulphonylureas
Over 86% lost at least 5% of their body weight, and 32% lost at least 20% over 68 weeks
Treatment decisions, however, should always be made with guidance from a qualified healthcare professional
Most side effects are transient and improve after 8-12 weeks
